Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
disregarded due to major methodological deficiencies
Reliability:
3 (not reliable)
Rationale for reliability incl. deficiencies:
other: documentation not sufficient for a reliable assessment of the chronic toxicity of the substance
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
publication
Title:
The toxicologic and pharmacologic effects of hafnium salts
Author:
Haley T.J., Raymond K., Komesu N. and Upham H.C.
Year:
1962
Bibliographic source:
Toxicology and applied pharmacologiy, vol 4: 238-246

Materials and methods

Principles of method if other than guideline:
The chronic toxicity of hafnium chloride was determined by including 0.01, 0.1, and 1 % of the compound in the diet of three groups of CFN rats, over a period of 12 weeks (doses not expressed in mg/kg bw). Each group contained 6 males and 6 females.
GLP compliance:
no
Remarks:
GLP did not exist in 1962

Test material

Constituent 1
Chemical structure
Reference substance name:
Hafnium tetrachloride
EC Number:
236-826-5
EC Name:
Hafnium tetrachloride
Cas Number:
13499-05-3
Molecular formula:
Cl4Hf
IUPAC Name:
hafnium tetrachloride

Test animals

Species:
rat
Strain:
other: CFN
Sex:
male/female

Administration / exposure

Route of administration:
oral: feed
Vehicle:
unchanged (no vehicle)
Duration of treatment / exposure:
12 weeks
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0.01 %
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
0.1 %
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
1 %
Basis:
nominal in diet
No. of animals per sex per dose:
6
Control animals:
yes

Examinations

Observations and examinations performed and frequency:
The following observations were made: total erythrocytes, total leucocytes, differential cell count, hemoglobin, hematocrit and body weight. At the conclusion of the period, the following tissues were subjected to histological examination: heart, lung, liver, kidney, pancreas, spleen, adrenal, and small intestine.

Results and discussion

Results of examinations

Clinical signs:
no effects observed
Mortality:
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
no effects observed
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
effects observed, treatment-related
Histopathological findings: neoplastic:
not specified
Details on results:
Histopathological examination revealed damage only in the liver: perinuclear vacuolization of the parenchymal cells and coarse granularity of the cytoplasm. Both sexes showed this damage in 5/6 animals at 1 %, whereas only 2/6 males and 1/6 females showed this damage at 0.1 % and 0.01 %.

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

Executive summary:

The chronic toxicity of hafnium chloride was determined by including 0.01, 0.1, and 1 % of the compound in the diet of three groups of CFN rats, over a period of 12 weeks (doses not expressed in mg/kg bw). Each group contained 6 males and 6 females. The following observations were made: total erythrocytes, total leucocytes, differential cell count, hemoglobin, hematocrit and body weight. At the conclusion of the period, the following tissues were subjected to histological examination: heart, lung, liver, kidney, pancreas, spleen, adrenal, and small intestine.

No effects on growth or hematological parameters. Histopathological examination revealed damage only in the liver: perinuclear vacuolization of the parenchymal cells and coarse granularity of the cytoplasm. Both sexes showed this damage in 5/6 animals at 1 %, whereas only 2/6 males and 1/6 females showed this damage at 0.1 % and 0.01 %.